These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21548724)

  • 21. The effect of duloxetine on primary pain symptoms in Parkinson disease.
    Djaldetti R; Yust-Katz S; Kolianov V; Melamed E; Dabby R
    Clin Neuropharmacol; 2007; 30(4):201-5. PubMed ID: 17762316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid utilization and health-care costs among patients with diabetic peripheral neuropathic pain treated with duloxetine vs. other therapies.
    Wu N; Chen SY; Hallett LA; Boulanger L; Fraser KA; Patel CK; Zhao Y
    Pain Pract; 2011; 11(1):48-56. PubMed ID: 20602718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The short- and long-term effect of duloxetine on painful physical symptoms in patients with generalized anxiety disorder: results from three clinical trials.
    Beesdo K; Hartford J; Russell J; Spann M; Ball S; Wittchen HU
    J Anxiety Disord; 2009 Dec; 23(8):1064-71. PubMed ID: 19643572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duloxetine use in employees with low back pain: treatment patterns and direct and indirect costs.
    Ivanova JI; Birnbaum HG; Kantor E; Schiller M; Swindle RW
    Pain Med; 2014 Jun; 15(6):1015-26. PubMed ID: 24529260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
    O'Connor AB
    J Pain; 2006 Nov; 7(11):867; author reply 867-8. PubMed ID: 17074629
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components.
    Morlion B
    Curr Med Res Opin; 2011 Jan; 27(1):11-33. PubMed ID: 21083513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Low back pain and fibromyalgia syndrome].
    Atzeni F; Sarzi-Puttini P
    Reumatismo; 2006; 58 Spec No.1():18-23. PubMed ID: 23631056
    [No Abstract]   [Full Text] [Related]  

  • 28. New hope in the treatment of painful symptoms in depression.
    Briley M
    Curr Opin Investig Drugs; 2003 Jan; 4(1):42-5. PubMed ID: 12625027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Back pain: guidelines for drug therapy. Utilize the therapeutic spectrum].
    Wörz R; Müller-Schwefe G; Stroehmann I; Zeuner L; Zieglgänsberger W; Zimmermann M
    MMW Fortschr Med; 2000 Feb; 142(5):27-33. PubMed ID: 10715936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duloxetine: an emerging evidence for fibromyalgia.
    Pae CU; Marks DC; Han C; Patkar AA; Masand PS
    Biomed Pharmacother; 2009 Jan; 63(1):69-71. PubMed ID: 18502090
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of depression in the presence of pain symptoms.
    Mohr P; Bitter I; Svestka J; Seifritz E; Karamustafalioglu O; Koponen H; Sartorius N
    Psychiatr Danub; 2010 Mar; 22(1):4-13. PubMed ID: 20305585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do antidepressant medications relieve chronic low back pain?
    Turner JA; Denny MC
    J Fam Pract; 1993 Dec; 37(6):545-53. PubMed ID: 8245805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
    Mease PJ; Russell IJ; Kajdasz DK; Wiltse CG; Detke MJ; Wohlreich MM; Walker DJ; Chappell AS
    Semin Arthritis Rheum; 2010 Jun; 39(6):454-64. PubMed ID: 19152958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.
    Russell JM; Weisberg R; Fava M; Hartford JT; Erickson JS; D'Souza DN
    Depress Anxiety; 2008; 25(7):E1-11. PubMed ID: 17587217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressants and the relief of osteoarthritic pain - findings from a study examining adjunctive duloxetine.
    Citrome L; Weiss-Citrome A
    Int J Clin Pract; 2012 May; 66(5):431-3. PubMed ID: 22432949
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological modulation of movement-evoked pain in a rat model of osteoarthritis.
    Chandran P; Pai M; Blomme EA; Hsieh GC; Decker MW; Honore P
    Eur J Pharmacol; 2009 Jun; 613(1-3):39-45. PubMed ID: 19376109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does pain cause the perception of fatigue in patients with chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
    Fishbain DA; Hall JA; Risser RC; Gonzales JS
    Pain Pract; 2009; 9(5):354-62. PubMed ID: 19500272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological validation of a model of cystitis pain in the mouse.
    Wantuch C; Piesla M; Leventhal L
    Neurosci Lett; 2007 Jun; 421(3):250-2. PubMed ID: 17574748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duloxetine status.
    Fishbain DA
    Pain Med; 2007 Sep; 8 Suppl 2():S25-6. PubMed ID: 17714112
    [No Abstract]   [Full Text] [Related]  

  • 40. Understanding and managing patients with chronic pain.
    Szumita RP; Szumita PM; Just N
    Oral Maxillofac Surg Clin North Am; 2010 Nov; 22(4):481-94. PubMed ID: 20970714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.